期刊论文详细信息
Veterinary Evidence
Should Levetiracetam or Imepitoin Be Used in Preference as Second-line Treatment in Pharmacoresistent Epileptic Cats?
Sophie Elizabeth Wyatt1 
[1] Queen Mother Hospital for Animals, Royal Veterinary CollegeHawkshead LaneHatfieldHertfordshireAL9 7TA;
关键词: Epilepsy;    Feline;    Imepitoin;    Phenobarbital;    Levetiracetam;   
DOI  :  10.18849/ve.v4i2.226
来源: DOAJ
【 摘 要 】

PICO question

In adult cats with idiopathic epilepsy, which is poorly controlled with phenobarbital monotherapy, should levetiracetam or imepitoin be used in preference as a second line treatment in order to reduce seizure frequency?

Clinical bottom line

There is currently insufficient evidence to reliably determine whether levetiracetam or imepitoin should be used in preference as a second line treatment for the management of cats with refractory idiopathic epilepsy. There is weak evidence however to suggest clinical efficacy of levetiracetam and imepitoin in management of cats with idiopathic epilepsy. Further studies which evaluate and directly compare the efficacy of second line anticonvulsants in feline epilepsy are needed.


Open Access Peer Reviewed

【 授权许可】

Unknown   

  文献评价指标  
  下载次数:0次 浏览次数:0次